Study of Role of Blood Microvescicles and Exosomes in Patients With Graft Occlusion After Aortocoronary Bypass Surgery
Maria Cecilia Hospital
300 participants
Jun 1, 2022
OBSERVATIONAL
Conditions
Summary
Coronary artery bypass graft (CABG) surgery is still the standard treatment of coronary revascularization for patients with severe coronary artery disease (CAD). Graft patency, together with completeness of revascularization, is a major determinant of long-term outcome following CABG. The surgical procedure elicits a persistent systemic inflammatory response associated with the activation of the hemostatic system leading to perturbation of endothelial and vascular function and activation of platelets and leukocytes. All of these events are the main players responsible for the early and late graft failure in a significant percentage of patients.
Eligibility
Inclusion Criteria5
- between the ages of 40 and 80
- Ejection fraction> 30%
- coronary artery bypass surgery
- informed consent
- Willingness to carry out the follow-up visits and the assessments required by the protocol
Exclusion Criteria4
- emergency intervention
- changes in liver or kidney function
- changes in coagulation factors
- associated interventions (valve replacement, carotid endarterectomy)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05411445